Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Tiziana’s Foralumab suppresses lung inflammation in Brazil Covid-19 trial

pharmaceutical-technologyFebruary 04, 2021

Tag: Tiziana , foralumab , COVID-19 , brazil , COVAXX

PharmaSources Customer Service